Emergence of N348I in the connection domain of reverse transcriptase with failure of first-line antiretroviral therapy in subtype C HIV-1 increases resistance to NRTI and NNRTI including etravirine

被引：0
|
作者：
Brehm, J. [1 ]
Koontz, D. [1 ]
Wallis, C. L. [2 ]
Conradie, F. [2 ]
Sanne, I. [2 ]
Wood, R. [3 ]
McIntyre, J. [4 ]
Stevens, W. [2 ,5 ]
Sluis-Cremer, N. [1 ]
Mellors, J. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Witwatersrand, Johannesburg, South Africa
[3] Univ Cape Town, Rondebosch, South Africa
[4] Anova Hlth Inst, Johannesburg, South Africa
[5] Natl Hlth Lab Serv, Johannesburg, South Africa
来源：
ANTIVIRAL THERAPY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
55
引用
收藏
页码：A71 / A71
页数：1
相关论文
共 36 条
  • [1] Frequent emergence of N348I in the connection domain of reverse transcriptase with virological failure of first-line NNRTI-containing regimens in South Africa
    Brehm, J.
    Wallis, C. L.
    Sluis-Cremer, N.
    Conradie, F.
    Ive, P.
    Orrell, C.
    Zeinecker, J.
    Sanne, I.
    Wood, R.
    McIntyre, J.
    Stevens, W.
    Mellors, J.
    ANTIVIRAL THERAPY, 2010, 15 : A126 - A126
  • [2] Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors
    Brehm, Jessica H.
    Koontz, Dianna L.
    Wallis, Carole L.
    Shutt, Kathleen A.
    Sanne, Ian
    Wood, Robin
    McIntyre, James A.
    Stevens, Wendy S.
    Sluis-Cremer, Nicolas
    Mellors, John W.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (05) : 737 - 745
  • [3] N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
    Yap, Soo-Huey
    Sheen, Chih-Wei
    Fahey, Jonathan
    Zanin, Mark
    Tyssen, David
    Lima, Viviane Dias
    Wynhoven, Brian
    Kuiper, Michael
    Sluis-Cremer, Nicolas
    Harrigan, P. Richard
    Tachedjian, Gilda
    PLOS MEDICINE, 2007, 4 (12): : 1887 - 1900
  • [4] Enhanced NRTI and NNRTI resistance is associated with mutations in the HIV-1 reverse transcriptase connection subdomain of subtype C patients
    Delviks-Frankenberry, K. A.
    Lengruber, R. B.
    Santos, A. F.
    Soares, M. A.
    Kearney, M.
    Maldarelli, F.
    Coffin, J. M.
    Pathak, V. K.
    ANTIVIRAL THERAPY, 2010, 15 : A78 - A78
  • [5] Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1
    McCormick, Adele L.
    Parry, Chris M.
    Crombe, Anne
    Goodall, Ruth L.
    Gupta, Ravindra K.
    Kaleebu, Pontiano
    Kityo, Cissy
    Chirara, Michael
    Towers, Greg J.
    Pillay, Deenan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1806 - 1809
  • [6] The Connection Domain Mutation N348I in HIV-1 Reverse Transcriptase Enhances Resistance to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation by Diminishing Viral Replication Capacity
    Xu, Hong-Tao
    Colby-Germinario, Susan P.
    Oliveira, Maureen
    Han, Yingshan
    Quan, Yudong
    Zanichelli, Veronica
    Wainberg, Mark A.
    JOURNAL OF VIROLOGY, 2014, 88 (03) : 1536 - 1547
  • [7] The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine
    Schuckmann, Matthew M.
    Marchand, Bruno
    Hachiya, Atsuko
    Kodama, Eiichi N.
    Kirby, Karen A.
    Singh, Kamalendra
    Sarafianos, Stefan G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (49) : 38700 - 38709
  • [8] EFFECT OF TRANSLOCATION DEFECTIVE REVERSE TRANSCRIPTASE INHIBITORS ON THE ACTIVITY OF N348I, A CONNECTION SUBDOMAIN DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE MUTANT
    Michailidis, E.
    Singh, K.
    Ryan, E. M.
    Hachiya, A.
    Ong, Y. T.
    Kirby, K. A.
    Marchand, B.
    Kodama, E. N.
    Mitsuya, H.
    Parniak, M. A.
    Sarafianos, S. G.
    CELLULAR AND MOLECULAR BIOLOGY, 2012, 58 (01) : 187 - 195
  • [9] Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV-1 Reverse Transcriptase
    von Wyl, Viktor
    Ehteshami, Maryam
    Symons, Jori
    Buergisser, Philippe
    Nijhuis, Monique
    Demeter, Lisa M.
    Yerly, Sabine
    Boeni, Juerg
    Klimkait, Thomas
    Schuurman, Rob
    Ledergerber, Bruno
    Goette, Matthias
    Guenthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07): : 1054 - 1062
  • [10] HIV-1 Reverse Transcriptase Connection Domain Mutations: Dynamics of Emergence and Implications for Success of Combination Antiretroviral Therapy
    von Wyl, Viktor
    Ehteshami, Maryam
    Demeter, Lisa M.
    Buergisser, Philippe
    Nijhuis, Monique
    Symons, Jori
    Yerly, Sabine
    Boeni, Juerg
    Klimkait, Thomas
    Schuurman, Rob
    Ledergerber, Bruno
    Goette, Matthias
    Guenthard, Huldrych F.
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 620 - 628
1234